Celularity (CELU) Insider Trading & Ownership $1.90 -0.11 (-5.47%) As of 02:35 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Celularity (NASDAQ:CELU) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.10%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$8.48MNumber OfInsiders Selling(Last 3 Years)0 Get CELU Insider Trade Alerts Want to know when executives and insiders are buying or selling Celularity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CELU Insider Buying and Selling by Quarter Celularity Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Kok Thay LimMajor ShareholderBuy2,141,098$2.50$5,352,745.00 10/5/2023Robert J HaririCEOBuy935,758$1.60$1,497,212.80 9/29/2023Robert J HaririCEOBuy906,453$1.70$1,540,970.10 11/30/2022Robert J HaririCEOBuy1,000$17.20$17,200.00 11/28/2022Robert J HaririCEOBuy4,000$17.40$69,600.00 (Data available from 1/1/2013 forward) CELU Insider Trading Activity - Frequently Asked Questions Who is on Celularity's Insider Roster? The list of insiders at Celularity includes Kok Thay Lim, and Robert J Hariri. Learn more on insiders at CELU. What percentage of Celularity stock is owned by insiders? 22.10% of Celularity stock is owned by insiders. Learn more on CELU's insider holdings. Which Celularity insiders have been buying company stock? The following insiders have purchased CELU shares in the last 24 months: Kok Thay Lim ($5,352,745.00), and Robert J Hariri ($3,038,182.90). How much insider buying is happening at Celularity? Insiders have purchased a total of 3,983,309 CELU shares in the last 24 months for a total of $8,390,927.90 bought. Celularity Key ExecutivesDr. Robert Joseph Hariri M.D. (Age 65)Ph.D., Founder, CEO & Chairman Compensation: $1.24MMr. David C. Beers C.F.A. (Age 54)Chief Financial Officer Compensation: $455.02kMr. John R. Haines (Age 66)Senior EVP, Global Manager & Chief Administrative Officer Compensation: $503.56kRamji KrishnanChief Technology OfficerCarlos RamirezSVP of Investor RelationsMr. Kyle Harold Fletcher Esq. (Age 39)Executive VP, General Counsel & Chief Compliance Officer Dr. Stephen A. Brigido D.P.M. (Age 48)President of Degenerative Diseases Dr. Adrian Kilcoyne M.B.A. (Age 53)M.D., M.P.H., Executive VP, Chief Medical Officer and Head of Global Affairs, Patient Safety & Patient Affairs Sharmila Koppisetti M.D.Senior Vice President of Clinical Dev. Immunology & Drug SafetyMr. Tim WilkSenior Vice President of Technical Operations More Insider Trading Tools from MarketBeat Related Companies Neoleukin Therapeutics Insider Ownership Larimar Therapeutics Insider Ownership ALT5 Sigma Insider Ownership Voyager Therapeutics Insider Ownership enGene Insider Ownership Ventyx Biosciences Insider Ownership Puma Biotechnology Insider Ownership Lifevantage Insider Ownership Aclaris Therapeutics Insider Ownership Alumis Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for June This page (NASDAQ:CELU) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersIs Tesla a buy right now?Wall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredYour portfolio has a dangerous blind spot (fix it now)The next overnight crash could happen any day. Will you be protected or exposed? Register now to learn how som...Ninjacators | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celularity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celularity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
